IMMUNOTECH-B (06978) released its interim results, with a net loss attributable to shareholders of 69.867 million yuan, a year-on-year reduction of 45.9%.

date
22:34 21/08/2026
avatar
GMT Eight
Eternal Tai Biological-B (06978) announced its results for the six months ending June 30, 2026. During this period, the group achieved other income of RMB 12.597 million, a year-on-year decrease of 3.4%; the loss attributable to shareholders was RMB 69.867 million, a year-on-year narrowing of 45.9%; basic loss per share was RMB 0.11.
IMMUNOTECH-B (06978) announced its performance for the six months ended June 30, 2026. During the period, the group achieved other income of RMB 12.597 million, a year-on-year decrease of 3.4%; the loss attributable to shareholders was RMB 69.867 million, a year-on-year reduction of 45.9%; and the basic loss per share was RMB 0.11.